What's new? We're glad you asked.
Stryker’s MultiGen 2 Radiofrequency Generator receives FDA 510(k) clearance
Kalamazoo, Michigan, USA – July 11, 2017 – Stryker announced today that it has received FDA 510(k) clearance for its MultiGen 2 RF Generator. This product provides physicians with the efficiency, control and reliability they need when performing radiofrequency ablation, a minimally invasive procedure that can provide lasting relief to those suffering from facet joint pain.1
Stryker’s AVAflex Vertebral Balloon System receives FDA 510(k) clearance
Kalamazoo, Michigan, USA – March 5, 2017 – Stryker announced today that its AVAflex Balloon System has received FDA 510(k) clearance and is, for the first time, available with Stryker’s market-leading bone cements and implants and the AutoPlex Mixing and Delivery System.
Stryker announces completion of the acquisition of vertebral compression fracture portfolio from BD
Kalamazoo, Michigan – April 21, 2016 – Stryker Corporation (NYSE: SYK) announced today it has completed the acquisition of the CareFusion vertebral compression fracture (VCF) portfolio of products from BD (Becton, Dickinson and Company) in an all cash transaction. The portfolio is composed of minimally invasive systems used in vertebroplasty and vertebral augmentation procedures. BD acquired these assets as a part of CareFusion’s portfolio in March of 2015.
1000-025-489 Rev B